Sheryl Stevenson

Sheryl brings a wealth of editorial experience to MJH Life Sciences’ Eye Care Network, having engaged with the readers and the greater ophthalmic community of Ophthalmology Times for more than 20 years. As Group Editorial Director, Sheryl’s purview extends across the print and digital network of Ophthalmology Times, Ophthalmology Times Europe, Modern Retina and Optometry Times. Prior to ophthalmology, Sheryl previously covered the fields of audiology and confectionery science/technology/manufacturing.

Sheryl is also passionate about the mission, vision and values of Ophthalmic World Leaders (OWL) and recently completed her term on its Board of Directors. She continues to volunteer as Editor-in-Chief of the organization’s EMPOWER Magazine. In 2013, she was honored with the group’s inaugural Rising Star Award.

In addition, she has served as a judge for Crain's Cleveland Business Health Care Heroes Awards program as well as the Jesse H. Neal National Business Journalism Awards.

Articles

Understanding fluid dynamics in wet macular degeneration

October 01, 2022

Video

At AAO 2022, Justis Ehlers, MD, presented a talk entitled, "Defining the Fluid Problem in Neovascular AMD: To Dry or Not to Dry?"

YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME

September 30, 2022

Video

Roger A. Goldberg, MD, MBA, discusses his 2022 AAO poster: "T&E-Based Personalized Treatment Interval Dynamics in the YOSEMITE/RHINE Trials of Faricimab in DME."

EURETINA 2022: Leadership discusses what to expect, outlines Women in Retina program

September 01, 2022

Video

Dara Conlon, Executive Vice President of EURETINA, and Prof. Anat Loewenstein, General Secretary of EURETINA, discuss some key features of this year's Congress.

KALAHARI study: Phase 2 early results indicate alternative treatment pathway for patients with DME is effective, durable

July 16, 2022

Video

Rahul Khurana, MD, discusses his 2022 ASRS talk, “Phase 2 Study of THR-149, a Plasma Kallikrein Inhibitor in Patients With DME Who Respond Suboptimally to Anti-VEGF Treatment (Month 6 Results of Part A of the KALAHARI Study),” which he presented in New York City, New York.

Elevated albumin to creatinine ratio associated with central subfield thickness fluctuations in patients with DME

July 16, 2022

Video

At ASRS in New York, Matthew Starr, MD, presented, “Factors Associated With Fluctuations in Central Subfield Thickness in Patients With Diabetic Macular Edema Using 2 Clinical Trial Databases.”

Expanding the therapeutic arsenal for noninfectious uveitis, uveitic macular edema

June 23, 2022

Video

Steven Yeh, MD, provides a brief overview of available therapies for noninfectious uveitis and uveitis macular edema.

Hypersonic vitrectomy: Novel technology for vitreous removal

June 09, 2022

Video

Though the speed of traditional guillotine cutters has increased significantly in recent years, there are certain limitations. With the advent of hypersonic vitrectomy, Sunir J. Garg, MD, FACS, explains how retinal surgeons can remove the vitreous gel with more efficiency.

YOSEMITE and RHINE trials yield durability, retinal fluid reduction, DME resolution with faricimab

June 06, 2022

Video

In the study, the faricimab molecule, which is a combined anti-Ang2 and anti-VEGF, performed better than the aflibercept drug in many different ways. Rishi P. Singh, MD, FASRS, summarizes some of these key findings.

First robot-assisted ab interno gonio-intervention paves the way for robotic eye surgery

March 09, 2022

Video

This new surgical technique offers precision down to the micron level, which is more precise than a surgeon can achieve by themselves.

Choriocapillaris, atrophy linked with neovascular AMD

February 11, 2022

Video

At Angiogenesis, Dr. SriniVas R. Sadda discusses how choriocapillaris may predict the rate of progression of atrophy.